Profile data is unavailable for this security.
About the company
Orchid Pharma Limited is an India-based pharmaceutical company. The Company is engaged in the manufacturing of integrated active pharmaceutical ingredients (API). It operates through the pharmaceutical segment. It has a multi-therapeutic presence across segments like anti-infectives, anti-inflammatory, central nervous system (CNS), cardiovascular segment (CVS), nutraceuticals and other oral and sterile products. Its pharmaceutical solutions include active pharmaceutical ingredients (APIs) and finished dosage forms. It offers APIs, including Cephalosporins-Orals, Cephalosporins-Injectables, Veterinary Products and Non-Antibodies. Its formulations include Cefixime Capsules, Acarbose Tablets, Acarbose Tablets, Clozapime Tablets, Clopidogrel Tablets, Desloratadine Tablets and Cefoperazone and Sulbactam for Injection, among others. Its subsidiaries include Orchid Europe Limited, Orchid Pharmaceuticals Inc., Bexel Pharmaceuticals Inc., and Diakron Pharmaceuticals, Inc., among others.
- Revenue in INR (TTM)8.19bn
- Net income in INR915.95m
- Incorporated1992
- Employees838.00
- LocationOrchid Pharma LtdOrchid Towers313-Valluvar Kottam High, NungambakkamCHENNAI 600034IndiaIND
- Phone+91 4 425211000
- Fax+91 4 428211002
- Websitehttp://www.orchidpharma.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Innova Captab Ltd | 10.81bn | 943.45m | 27.50bn | -- | 26.92 | -- | 24.93 | 2.54 | 17.85 | 17.85 | 202.59 | -- | -- | -- | -- | -- | -- | 10.82 | -- | 18.38 | 32.64 | 25.95 | 8.73 | 8.04 | -- | 6.45 | -- | -- | 16.72 | 24.90 | 38.84 | 36.55 | 104.14 | -- |
| Indoco Remedies Ltd | 18.17bn | 984.70m | 27.70bn | 6.10k | 28.56 | 2.50 | 14.66 | 1.52 | 10.52 | 10.52 | 193.15 | 120.38 | 0.9557 | 1.65 | 4.80 | -- | 5.10 | 6.88 | 7.02 | 9.85 | 69.23 | 66.66 | 5.34 | 6.93 | 0.9825 | 4.01 | 0.377 | 12.67 | 8.91 | 13.41 | -30.78 | -- | 34.54 | 37.97 |
| Supriya Lifescience Ltd | 5.70bn | 1.19bn | 29.54bn | 392.00 | 24.80 | 3.62 | 21.89 | 5.18 | 14.80 | 14.80 | 70.87 | 101.31 | 0.655 | 2.21 | 5.81 | -- | 13.68 | 19.08 | 15.19 | 24.04 | 61.12 | 58.71 | 20.88 | 24.71 | 4.06 | 66.40 | 0.0067 | 2.88 | 23.74 | 15.47 | 32.56 | 24.75 | 83.79 | -- |
| Gufic BioSciences Ltd | 8.07bn | 861.36m | 30.89bn | 1.63k | 35.20 | 5.80 | 29.94 | 3.83 | 8.75 | 8.75 | 81.90 | 53.11 | 0.8258 | 2.03 | 3.01 | -- | 8.82 | 11.46 | 13.32 | 19.21 | 51.67 | 46.99 | 10.68 | 10.46 | 1.08 | 8.37 | 0.3847 | -- | 16.80 | 18.12 | 8.07 | 31.46 | 53.83 | 14.87 |
| Hikal Ltd | 17.85bn | 696.00m | 35.12bn | 2.14k | 50.42 | 2.96 | 18.76 | 1.97 | 5.65 | 5.65 | 144.77 | 96.32 | 0.7325 | 2.66 | 3.60 | -- | 2.86 | 5.07 | 4.03 | 7.51 | 53.79 | 47.22 | 3.90 | 5.86 | 0.8761 | 2.65 | 0.4077 | 16.88 | -11.79 | 2.34 | -11.20 | -7.55 | 9.72 | 0.00 |
| Unichem Laboratories Ltd | 17.05bn | -704.74m | 38.21bn | 3.12k | -- | 1.62 | 89.35 | 2.24 | -10.02 | -10.02 | 238.88 | 335.54 | 0.5359 | 0.9995 | 2.84 | -- | -2.22 | -1.67 | -2.81 | -2.03 | 61.02 | 57.79 | -4.13 | -3.99 | 1.40 | -0.5733 | 0.0948 | -- | 26.94 | 7.64 | 65.15 | -- | -35.00 | -- |
| Advanced Enzyme Technologies Ltd | 6.24bn | 1.33bn | 40.57bn | 338.00 | 30.41 | 3.06 | 23.56 | 6.50 | 11.93 | 11.93 | 55.83 | 118.41 | 0.4219 | 1.06 | 6.27 | -- | 9.26 | 10.82 | 10.23 | 11.93 | 76.83 | 72.81 | 21.95 | 24.59 | 6.22 | 57.81 | 0.0334 | 15.17 | 15.39 | 8.26 | 26.19 | 3.72 | 27.85 | 53.42 |
| Aarti Drugs Ltd | 25.29bn | 1.71bn | 43.84bn | 1.50k | 25.63 | 3.42 | 19.66 | 1.73 | 18.61 | 18.61 | 274.44 | 139.40 | 1.04 | 3.35 | 3.22 | -- | 7.07 | 9.73 | 10.98 | 15.74 | 33.65 | 24.96 | 6.79 | 8.25 | 1.05 | 7.91 | 0.3056 | -- | -6.90 | 10.13 | 3.07 | 13.82 | 24.96 | -- |
| Shilpa Medicare Ltd | 11.51bn | 318.74m | 47.49bn | 1.03k | 131.96 | 2.33 | 33.96 | 4.12 | 3.68 | 3.68 | 134.51 | 208.37 | 0.3841 | 1.23 | 3.21 | -- | 1.07 | 2.84 | 1.41 | 3.65 | 64.63 | 61.37 | 2.78 | 7.03 | 0.7671 | 1.41 | 0.3424 | -- | 9.66 | 9.44 | 198.15 | -22.26 | -9.26 | -- |
| Orchid Pharma Ltd | 8.19bn | 915.95m | 50.86bn | 838.00 | 52.39 | 4.35 | 39.82 | 6.21 | 19.14 | 19.14 | 169.90 | 230.58 | 0.5897 | 1.97 | 3.99 | -- | 6.80 | -0.9734 | 8.80 | -1.40 | 40.87 | 43.32 | 11.53 | -2.40 | 2.03 | 4.68 | 0.1031 | -- | 23.05 | 6.43 | 73.59 | 5.84 | 57.79 | -- |
| Aarti Pharmalabs Ltd | 18.53bn | 2.17bn | 50.93bn | 1.40k | 23.48 | 2.90 | 17.56 | 2.75 | 23.94 | 23.94 | 204.45 | 193.89 | 0.7698 | 1.64 | 3.86 | -- | 9.01 | -- | 12.30 | -- | 44.90 | -- | 11.71 | -- | 1.01 | 18.17 | 0.1397 | -- | -4.76 | -- | 12.10 | -- | -- | -- |
| Blue Jet Healthcare Ltd | 7.12bn | 1.64bn | 66.32bn | -- | 40.48 | 7.85 | 34.57 | 9.32 | 9.44 | 9.44 | 41.04 | 48.73 | 0.7409 | 2.46 | 3.42 | -- | 17.05 | -- | 21.25 | -- | 55.82 | -- | 23.01 | -- | 2.80 | 1,257.13 | 0.00 | -- | -1.30 | -- | 2.33 | -- | -- | -- |
| Sun Pharma Advanced Research Co Ltd | 755.50m | -3.87bn | 66.80bn | 407.00 | -- | 53.12 | -- | 88.42 | -11.93 | -11.93 | 2.33 | 3.87 | 0.1123 | -- | 3.13 | -- | -57.57 | -61.70 | -85.93 | -119.31 | 62.77 | 76.08 | -512.52 | -163.40 | -- | -245.33 | 0.3414 | -- | -68.36 | -16.20 | -73.96 | -- | 15.40 | -- |
| Marksans Pharma Ltd | 21.03bn | 3.17bn | 67.32bn | 1.40k | 21.08 | -- | 17.39 | 3.20 | 7.05 | 7.05 | 46.71 | -- | -- | -- | -- | 15,024,090.00 | -- | 14.78 | -- | 19.58 | 51.88 | 50.16 | 15.21 | 13.01 | -- | 44.45 | -- | 5.49 | 24.23 | 15.20 | 44.29 | 51.89 | 6.61 | 58.49 |
| F D C Ltd | 19.43bn | 3.05bn | 70.42bn | 6.37k | 23.24 | 3.36 | 20.41 | 3.62 | 18.61 | 18.61 | 118.69 | 128.81 | 0.8077 | 1.83 | 16.19 | -- | 12.68 | 12.05 | 14.56 | 13.73 | 66.23 | 62.81 | 15.70 | 15.85 | 2.18 | 74.02 | 0.0097 | -- | 8.92 | 12.24 | 57.30 | 12.45 | 16.93 | -- |
Data as of May 31 2024. Currency figures normalised to Orchid Pharma Ltd's reporting currency: Indian Rupee INR
16.04%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| quant Money Managers Ltd.as of 30 Sep 2023 | 3.23m | 6.36% |
| Invesco Asset Management (India) Pvt Ltd.as of 30 Apr 2024 | 2.02m | 3.98% |
| Nippon Life India Asset Management Ltd. (Invt Mgmt)as of 30 Sep 2023 | 1.00m | 1.97% |
| Carnelian Asset Management & Advisors Pvt Ltd.as of 30 Sep 2023 | 618.92k | 1.22% |
| JM Financial Asset Management Ltd.as of 30 Apr 2024 | 424.08k | 0.84% |
| UTI Asset Management Co. Ltd. (Investment Management)as of 30 Apr 2024 | 411.80k | 0.81% |
| Bajaj Finserv Asset Management Ltd.as of 30 Apr 2024 | 263.38k | 0.52% |
| Bandhan Asset Management Co. Ltd.as of 30 Apr 2024 | 115.53k | 0.23% |
| ITI Asset Management Ltd. (India)as of 30 Apr 2024 | 45.00k | 0.09% |
| Dimensional Fund Advisors LPas of 09 May 2024 | 14.31k | 0.03% |
More ▼
Data from 30 Sep 2023 - 30 May 2024Source: FactSet Research Systems Inc.
